WSJ.com: US Business
Ranbaxy Recalls Generic Lipitor in U.S.
March 7, 2014 4:08 p.m. ET
Ranbaxy Laboratories Ltd., the India-based generic-drug maker beset by manufacturing-quality problems, has issued another recall of generic versions of the cholesterol drug Lipitor in the U.S. due to a potential dose mix-up.
A Ranbaxy unit recalled from U.S. pharmacies more than 64,000 bottles of 10-milligram tablets of atorvastatin calcium—the generic name for Lipitor's active ingredient—because of the possibility that some bottles contained higher-dose, 20-milligram tablets, the U.S. Food and Drug Administration said in...
0 comments:
Post a Comment